Microsoft and Anthropic in Talks for Custom AI Chip Supply Amid 5 Billion Investment Ponyai Assures Operations Unaffected by SelfDriving Car Safety Review Japan and Philippines to Begin Talks on IntelligenceSharing Pact Bolstering Regional Security Ties Googles Homepage Overhaul AI Integration Marks a Strategic Shift for Search Giant AIRelated Layoffs Stock Boost Potential Questioned by New Data SpaceX Scrubs Starship Test Flight Targets Friday for Debut of Upgraded V3 Rocket Copa Holdings CPA Q1 2026 Earnings EPS Surges 215 Above Estimates Stock Holds Steady Intensity Therapeutics Q1 2026 Earnings NarrowerThanExpected Loss Amid Clinical Progress ALOT Q1 2026 Earnings Negative EPS Amidst Strategic Transitions Allient Inc ALNT Q1 2026 Earnings EPS Misses Estimates Amid Operational Headwinds Stock Edges Higher FFIC Q1 2026 Earnings EPS Misses Estimates Amid Challenging Rate Environment RVMD Q1 2026 Earnings EPS Miss Signals Higher RD Spending Amid LateStage Pipeline Push GPAct III Acquisition Corp GPAT Holds Steady at 1080 as SPAC Awaiting Next Catalyst Space Asset Acquisition Corp Warrants SAAQW Surge 106 as Momentum Builds Toward Key Resistance Elauwit Connection ELWT Edges Higher as Stock Tests Key Resistance Levels PennyMac Mortgage Investment Trust 900 Senior Notes PMTW Hold Steady Near Par Technical and Fundamental Outlook Profound Medical PROF Hovers Near Support Amid Modest Decline Oil Prices Decline as USIran Talks Spur Hope for Hormuz Strait Deescalation SP 500 Edges Higher as Healthcare Outpaces Communication Services BP Chairman Abruptly Removed Amid Allegations of Bullying and Overbearing Conduct Kazatomprom Reports 17 Production Surge in Third Quarter Highlighting Operational Strength Arm Holdings Stock Surges 46 as Market Anticipates Fivefold Profit Growth Michael Saylor Tokenization May Allow Investors to Shop for Yield Challenging Traditional Banking Meta Broadcom and Industry Leaders Launch 125 Million Semiconductor Research Hub at UCLA Telomir Pharmaceuticals Inc TELO Q4 2025 Earnings WiderthanExpected Loss Highlights DevelopmentStage Challenges LENZ Therapeutics LENZ Edges Lower as Stock Tests Support at 730